Cargando…

Tissue-protective activity of selenomethionine and D-panthetine in B16 melanoma-bearing mice under doxorubicin treatment is not connected with their ROS scavenging potential

AIM: To evaluate molecular mechanisms of tissue-protective effects of antioxidants selenomethionine (SeMet) and D-pantethine (D-Pt) applied in combination with doxorubicin (Dx) in B16 melanoma-bearing-mice. METHODS: Impact of the chemotherapy scheme on a survival of tumor-bearing animals, general ne...

Descripción completa

Detalles Bibliográficos
Autores principales:	Panchuk, Rostyslav R., Skorokhyd, Nadia R., Kozak, Yuliya S., Lehka, Liliya V., Moiseenok, Andrey G., Stoika, Rostyslav S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Croatian Medical Schools 2017
Materias:	Basic Science
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5410729/ https://www.ncbi.nlm.nih.gov/pubmed/28409500 http://dx.doi.org/10.3325/cmj.2017.58.171

Ejemplares similares

Antioxidants selenomethionine and D-pantethine decrease the negative side effects of doxorubicin in NL/Ly lymphoma-bearing mice
por: Panchuk, Rostyslav R., et al.
Publicado: (2016)

Specific antioxidant compounds differentially modulate cytotoxic activity of doxorubicin and cisplatin: in vitro and in vivo study
por: Panchuk, Rostyslav, et al.
Publicado: (2014)

Differential pro-apoptotic effects of synthetic 4-thiazolidinone derivative Les-3288, doxorubicin and temozolomide in human glioma U251 cells
por: Коbylinska, Lesya I., et al.
Publicado: (2017)

Cannabimimetic N-Stearoylethanolamine as “Double-Edged Sword” in Anticancer Chemotherapy: Proapoptotic Effect on Tumor Cells and Suppression of Tumor Growth versus Its Bio-Protective Actions in Complex with Polymeric Carrier on General Toxicity of Doxorubicin In Vivo
por: Panchuk, Rostyslav, et al.
Publicado: (2023)

Magnetic Temperature-Sensitive Solid-Lipid Particles for Targeting and Killing Tumor Cells
por: Świętek, Małgorzata, et al.
Publicado: (2020)

Complex of C(60) Fullerene with Doxorubicin as a Promising Agent in Antitumor Therapy
por: Prylutska, Svitlana V., et al.
Publicado: (2015)

Putative anticancer potential of novel 4-thiazolidinone derivatives: cytotoxicity toward rat C6 glioma in vitro and correlation of general toxicity with the balance of free radical oxidation in rats
por: Коbylinska, Lesya I., et al.
Publicado: (2016)

Cytotoxicity of doxorubicin-conjugated poly[N-(2-hydroxypropyl)methacrylamide]-modified γ-Fe(2)O(3) nanoparticles towards human tumor cells
por: Plichta, Zdeněk, et al.
Publicado: (2018)

4-Thiazolidinone derivative Les-3833 effectively inhibits viability of human melanoma cells through activating apoptotic mechanisms
por: Finiuk, Nataliya, et al.
Publicado: (2017)

Covalent Conjugate of Ser-Pro-Cys Tripeptide with PEGylated Comb-Like Polymer as Novel Killer of Human Tumor Cells
por: Manko, Nazar, et al.
Publicado: (2022)

Multitarget Anticancer Agents Based on Histone Deacetylase and Protein Kinase CK2 Inhibitors
por: Martínez, Regina, et al.
Publicado: (2020)

Enhanced Proapoptotic Effects of Water Dispersed Complexes of 4-Thiazolidinone-Based Chemotherapeutics with a PEG-Containing Polymeric Nanocarrier
por: Kobylinska, L., et al.
Publicado: (2019)

Landomycins as glutathione-depleting agents and natural fluorescent probes for cellular Michael adduct-dependent quinone metabolism
por: Terenzi, Alessio, et al.
Publicado: (2021)

Microvesicles: ROS scavengers and ROS producers
por: Bodega, G., et al.
Publicado: (2019)

2337: Doxorubicin exposure in vitro stimulates ROS production and directly suppresses cardiac fibroblast proliferation
por: Mancilla, Trevi A., et al.
Publicado: (2018)

Visualization of melanoma tumor with lectin-conjugated rare-earth doped fluoride nanocrystals
por: Dumych, Tetiana, et al.
Publicado: (2014)

Characteristics of Potential Protein Biomarkers Extracted with 10% TCA from Blood Serum of Non-Hodgkin’s Lymphoma and Multiple Myeloma Patients
por: Myronovskij, Severyn, et al.
Publicado: (2017)

Detection of novel auto-antigens in patients with recurrent miscarriage: description of an approach and preliminary findings
por: Kit, Yuriy, et al.
Publicado: (2014)

Magnetic poly(2-hydroxyethyl methacrylate) microspheres for affinity purification of monospecific anti-p46 kDa/Myo1C antibodies for early diagnosis of multiple sclerosis patients
por: Horák, Daniel, et al.
Publicado: (2017)

Albumin-Based Zn (II)-Quercetin Enzyme Mimic Scavenging ROS for Protection against Cardiotoxicity Induced by Doxorubicin
por: Shao, Zehua, et al.
Publicado: (2022)

The behavior of ROS-scavenging nanoparticles in blood
por: Shimizu, Madoka, et al.
Publicado: (2014)

ROS-Scavenging Nanomaterials to Treat Periodontitis
por: Sui, Lihua, et al.
Publicado: (2020)

Reduction of gene repair by selenomethionine with the use of single-stranded oligonucleotides
por: Schwartz, Timothy R, et al.
Publicado: (2007)

Identification of a 48 kDa form of unconventional myosin 1c in blood serum of patients with autoimmune diseases
por: Myronovkij, Severyn, et al.
Publicado: (2015)

Selenomethionine Incorporation into Amyloid Sequences Regulates Fibrillogenesis and Toxicity
por: Martínez, Javier, et al.
Publicado: (2011)

Selenium Kinetics in Humans Change Following 2 Years of Supplementation With Selenomethionine
por: Patterson, Blossom H., et al.
Publicado: (2021)

Selenomethionine against titanium particle-induced osteolysis by regulating the ROS-dependent NLRP3 inflammasome activation via the β-catenin signaling pathway
por: Yu, Ruixuan, et al.
Publicado: (2023)

Selenomethionine and methyl selenocysteine: multiple-dose pharmacokinetics in selenium-replete men
por: Marshall, James R., et al.
Publicado: (2017)

Antiproliferative Copper(II) Complexes Bearing Mixed Chelating Ligands: Structural Characterization, ROS Scavenging, In Silico Studies, and Anti-Melanoma Activity
por: Olar, Rodica, et al.
Publicado: (2022)

Selenomethionine attenuates allergic effector responses in human primary mast cells
por: Zhao, Xiaoli, et al.
Publicado: (2022)

Differential Acute Effects of Selenomethionine and Sodium Selenite on the Severity of Colitis
por: Hiller, Franziska, et al.
Publicado: (2015)

Supramolecular self-assembly of EGCG-selenomethionine nanodrug for treating osteoarthritis
por: Yu, Haichao, et al.
Publicado: (2023)

Significant Reduction of Murine Renal Ischemia-Reperfusion Cell Death Using the Immediate-Acting PrC-210 Reactive Oxygen Species Scavenger
por: Bath, Natalie M., et al.
Publicado: (2019)

4-Thiazolidinone-Bearing Hybrid Molecules in Anticancer Drug Design
por: Roszczenko, Piotr, et al.
Publicado: (2022)

Elemene Nanoemulsion Inhibits Metastasis of Breast Cancer by ROS Scavenging
por: Han, Bo, et al.
Publicado: (2021)

Bioceramic Scaffolds with Antioxidative Functions for ROS Scavenging and Osteochondral Regeneration
por: Deng, Cuijun, et al.
Publicado: (2022)

ROS-Scavenging Selenofluoxetine Derivatives Inhibit In Vivo Serotonin Reuptake
por: Ribaudo, Giovanni, et al.
Publicado: (2022)

Additional phase information from UV damage of selenomethionine labelled proteins
por: de Sanctis, Daniele, et al.
Publicado: (2011)

Experimental phase determination with selenomethionine or mercury-derivatization in serial femtosecond crystallography
por: Yamashita, Keitaro, et al.
Publicado: (2017)

Exposure to selenomethionine causes selenocysteine misincorporation and protein aggregation in Saccharomyces cerevisiae
por: Plateau, Pierre, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_g0cge4n22eiol1a8vvak5fplif